Tech Mahindra leverages Artificial Intelligence to Research Potential Therapeutic Drugs for COVID-19

Tech Mahindra conducted molecular docking studies across 19 FDA approved ligands (binding agent) and anti-viral drugs on the RNA of virus.

The story highlights the use of Artificial Intelligence for researching COVID-19 treatment drugs at Tech Mahindra’s research and development arm ‘Makers Lab’. The story further illuminates the collaboration with a bio-scientist for plausible therapeutic drugs and research laboratories for synthesizing and testing these compounds. Read More